Curis | CRIS - Cost Of Sales


Curis reported $10.27M in Cost of Sales for its fiscal quarter ending in June of 2024.





Cost Of Sales Change Date
Alaunos Therapeutics USD 0 18K Sep/2024
Amgen USD 1.79B 128M Dec/2025
AstraZeneca USD 3.27B 471M Dec/2025
Bayer EUR 4.5B 194M Dec/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
CSL USD 3.87B 2.08B Dec/2025
Curis USD 10.27M 610K Jun/2024
Eli Lilly USD 3.37B 363.7M Dec/2025
Exelixis USD 26.48M 7.91M Dec/2025
Gilead Sciences USD 1.62B 50M Dec/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
Incyte USD 121.18M 22.18M Dec/2025
Merck USD 3.32B 531M Dec/2025
Novartis USD 3.54B 3M Dec/2025
Pfizer USD 6.29B 2.12B Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 4.29B 421M Dec/2025
Takeda JPY 401.15B 184.07B Dec/2025
TG Therapeutics USD 38.14M 10.05M Dec/2025
Verastem USD 0 0 Dec/2021
Xoma 116K 112.7K Jun/2024